We are live on ! Find out more
Wells Fargo

Wells Fargo Portfolio holdings

AUM $530B
1-Year Est. Return 22.01%
 

Wells Fargo & Company, founded in 1852 by Henry Wells and William Fargo, is a major American financial institution headquartered in San Francisco, California, known for its extensive retail banking network and historical roots in the American West. Offering a wide range of services—including consumer banking, mortgages, wealth management, and commercial finance—it manages trillions in assets and serves millions of customers through thousands of branches and ATMs across the U.S. Despite its prominence, Wells Fargo faced significant scrutiny following a 2016 scandal involving millions of unauthorized accounts, leading to leadership changes and regulatory penalties, though it has since focused on rebuilding trust and enhancing digital banking capabilities. With a legacy tied to stagecoaches and a modern focus on diversified financial services, Wells Fargo remains a key player in the U.S. banking sector.

This Fund
S&P 500
This Quarter Est. Return
+10.74%
1 Year Est. Return
+22.01%
3 Year Est. Return
+63.17%
5 Year Est. Return
+74.8%
10 Year Est. Return
+385.76%
AUM
$383B
AUM Growth
+$42B
Cap. Flow
+$6.12B
Cap. Flow %
1.6%
Top 10 Hldgs %
17.72%
Holding
7,882
New
408
Increased
3,686
Reduced
2,463
Closed
394

Sector Composition

Rank Sector Weight
1 Technology 14.38%
2 Healthcare 7.44%
3 Financials 7.25%
4 Industrials 6.34%
5 Consumer Discretionary 5.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CYT
6201
DELISTED
Cyteir Therapeutics, Inc. Common Stock
CYT
$447 ﹤0.01%
147
+8
+6% +$24
GURU icon
6202
Global X Guru Index ETF
GURU
$63.5M
$444 ﹤0.01%
11
-6,779
-100% -$250K
HOOK
6203
DELISTED
HOOKIPA Pharma
HOOK
$437 ﹤0.01%
54
-7
-11% -$39
AXDX
6204
DELISTED
Accelerate Diagnostics
AXDX
$435 ﹤0.01%
111
-113
-50% -$598
FUSB icon
6205
First US Bancshares
FUSB
$90.8M
$433 ﹤0.01%
42
+3
+8% +$27
FBYD icon
6206
Falcon's Beyond
FBYD
$494M
$431 ﹤0.01%
+42
New +$471
GLSI icon
6207
Greenwich LifeSciences
GLSI
$211M
$431 ﹤0.01%
41
+3
+8% +$30
DRMA icon
6208
Dermata Therapeutics
DRMA
$4.42M
$429 ﹤0.01%
5
QXO
6209
QXO Inc
QXO
$17.4B
$428 ﹤0.01%
3
KRON
6210
DELISTED
Kronos Bio
KRON
$426 ﹤0.01%
341
+18
+6% +$20
SURG icon
6211
SurgePays
SURG
$7.27M
$426 ﹤0.01%
66
+4
+6% +$21
RENX
6212
RenX Enterprises
RENX
$5.1M
$422 ﹤0.01%
1
TPST icon
6213
Tempest Therapeutics
TPST
$14.6M
$422 ﹤0.01%
7
+3
+75% +$142
GEG icon
6214
Great Elm Group
GEG
$69.3M
$419 ﹤0.01%
216
+13
+6% +$25
XTNT icon
6215
Xtant Medical Holdings
XTNT
$62.3M
$418 ﹤0.01%
370
+21
+6% +$25
RSSS icon
6216
Research Solutions
RSSS
$72.2M
$416 ﹤0.01%
160
+9
+6% +$22
ASMB icon
6217
Assembly Biosciences
ASMB
$529M
$415 ﹤0.01%
42
+10
+31% +$95
ESOA icon
6218
Energy Services of America
ESOA
$292M
$413 ﹤0.01%
69
+4
+6% +$18
SPRB
6219
Spruce Biosciences
SPRB
$129M
$413 ﹤0.01%
2
JOB icon
6220
GEE Group
JOB
$22.5M
$409 ﹤0.01%
818
+38
+5% +$21
CHRN
6221
ChronoScale Holdings
CHRN
$3.04B
$406 ﹤0.01%
11
+1
+10% +$19
CPHC icon
6222
Canterbury Park Holding Corp
CPHC
$80M
$405 ﹤0.01%
20
+1
+5% +$20
YARW
6223
Yarrow Bioscience, Inc. Common Stock
YARW
$111M
$400 ﹤0.01%
3
+1
+50% +$156
SRT
6224
DELISTED
Startek Inc.
SRT
$399 ﹤0.01%
90
+5
+6% +$21
ASPI icon
6225
ASP Isotopes
ASPI
$558M
$390 ﹤0.01%
218
+95
+77% +$139

Similar funds

Wells Fargo's Q4 2023 Portfolio in Review

As of Q4 2023, Wells Fargo held 7,882 positions worth $383B, up 12% from $341B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Wells Fargo's Q4 2023 filing shows 408 new, 3,686 increased, 2,463 reduced and 394 closed positions. Its largest new stake was FT Vest US Equity Buffer ETF April: 1,231,825 shares worth $43.1M. The largest sale was Invesco QQQ Trust, an estimated $487M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.

  • Wells Fargo's largest Q4 2023 buy was FT Vest US Equity Buffer ETF April: 1,231,825 shares worth $43.1M.
  • Wells Fargo added most to State Street SPDR S&P 500 ETF Trust in Q4 2023, an estimated $790M increase.
  • Wells Fargo's biggest Q4 2023 reduction was Invesco QQQ Trust, cutting an estimated $487M.
  • Wells Fargo fully exited Activision Blizzard in Q4 2023, selling an estimated $65.2M.
  • Wells Fargo's ten largest holdings make up 18% of its $383B portfolio in Q4 2023.
  • Wells Fargo opened 408 new positions and closed 394 in Q4 2023.
  • Wells Fargo's portfolio value rose 12% quarter-over-quarter to $383B.

Based on Wells Fargo's 13F filing for Q4 2023, filed 9 Feb 2024.